Published in J Natl Cancer Inst on March 06, 1996
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol (2015) 2.70
Current treatment for colorectal liver metastases. World J Gastroenterol (2011) 1.38
Indicators for treatment strategies of colorectal liver metastases. Ann Surg (2000) 1.26
C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci (2004) 1.14
Actual role of radiofrequency ablation of liver metastases. Eur Radiol (2007) 1.07
Relation between depression and circulating immune products in patients with advanced colorectal cancer. J R Soc Med (1998) 0.99
Colorectal liver metastases. Int J Surg Oncol (2011) 0.93
Selective internal radiation therapy (SIRT): a new modality for treating patients with colorectal liver metastases. HPB (Oxford) (2004) 0.89
Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancer. Int J Clin Oncol (2009) 0.88
Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis. Hippokratia (2008) 0.88
Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery. Ann Surg (2007) 0.87
Quantitative detection of lac-Z-transfected CC531 colon carcinoma cells in an orthotopic rat liver metastasis model. Clin Exp Metastasis (1999) 0.87
Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than 1 litre. Br J Cancer (1997) 0.81
Surrogacy assessment using principal stratification with multivariate normal and Gaussian copula models. Clin Trials (2014) 0.81
Hepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancer. J Gastrointest Oncol (2015) 0.81
Clinical significance of and future perspectives for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer. Surg Today (2012) 0.80
Current directions in chemotherapy for colorectal cancer. J Gastroenterol (2006) 0.79
Fusion imaging using a hybrid SPECT-CT camera improves port perfusion scintigraphy for control of hepatic arterial infusion of chemotherapy in colorectal cancer patients. Eur J Nucl Med Mol Imaging (2005) 0.79
Hepatic artery chemotherapy in the management of colorectal metastases. Proc (Bayl Univ Med Cent) (2002) 0.76
Postoperative prophylactic hepatic arterial infusion chemotherapy for stage III colorectal cancer: a retrospective study. Onco Targets Ther (2016) 0.75
First-line treatment with hepatic arterial infusion plus capecitabine vs capecitabine alone for elderly patients with unresectable colorectal liver metastases. Cancer Biol Ther (2016) 0.75
Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients. Med Devices (Auckl) (2009) 0.75
Evaluating the clinical and economic trade-offs of hepatic arterial infusion. J Natl Cancer Inst (1996) 0.75
Advances and directions in chemotherapy using implantable port systems for colorectal cancer: a historical review. Surg Today (2013) 0.75
The role of chemotherapy in colon cancer. Ochsner J (2002) 0.75
Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis. Chin J Cancer Res (2017) 0.75
Randomized controlled trial evaluating the effectiveness of hepatic artery infusion (HAI) chemotherapy following curative resection of hepatic colorectal metastases. Langenbecks Arch Surg (2000) 0.75
Treatment Options in Colorectal Liver Metastases: Hepatic Arterial Infusion. Visc Med (2017) 0.75
Marginal effects of regional intra-arterial chemotherapy as an alternative treatment option in advanced pancreatic carcinoma. Langenbecks Arch Surg (2003) 0.75
Transcatheter arterial chemoembolization with docetaxel-loaded microspheres controls heavily pretreated unresectable liver metastases from colorectal cancer: a case study. Int J Clin Oncol (2011) 0.75
Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet (2000) 12.56
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science (1994) 7.10
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer (1994) 5.63
Plasmid vectors for the genetic analysis and manipulation of rhizobia and other gram-negative bacteria. Methods Enzymol (1986) 5.58
Customised antenatal growth charts. Lancet (1992) 5.34
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol (2001) 5.25
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst (2001) 5.09
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med (1995) 4.75
Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep Med (2001) 4.67
The Human Connectome Project: a data acquisition perspective. Neuroimage (2012) 4.64
Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J (1997) 4.53
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg (1997) 4.47
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol (2001) 4.06
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain (2005) 3.99
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol (2002) 3.91
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol (1998) 3.79
An adjustable fetal weight standard. Ultrasound Obstet Gynecol (1995) 3.70
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest (1987) 3.29
Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer. Lancet (2000) 3.27
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol (2001) 3.25
Center for Birth Defects Information Services. Birth Defects Orig Artic Ser (1980) 3.09
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol (1997) 3.08
5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. Cancer (1999) 3.06
Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet (1996) 3.02
Strategies for the prevention and control of obesity in the school setting: systematic review and meta-analysis. Int J Obes (Lond) (2008) 2.93
Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development (1999) 2.89
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol (2002) 2.87
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol (2001) 2.73
Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol (1996) 2.71
Fraud in medical research: an international survey of biostatisticians. ISCB Subcommittee on Fraud. Control Clin Trials (2000) 2.67
Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2. J Exp Med (1983) 2.61
Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS (2000) 2.61
The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol (1996) 2.57
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock (1991) 2.49
Localization of the X inactivation centre on the human X chromosome in Xq13. Nature (1991) 2.48
Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res (1994) 2.46
Leptin secretion and leptin receptor in the human stomach. Gut (2000) 2.46
Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell (1999) 2.42
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer (1999) 2.40
Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA (2000) 2.35
Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer (2000) 2.29
The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage (2006) 2.27
Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol (1993) 2.27
Plasma membrane proton ATPase Pma1p requires raft association for surface delivery in yeast. Mol Biol Cell (2001) 2.27
Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord (2004) 2.26
Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. J Clin Oncol (2004) 2.24
Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial. FECG Study Group. Lancet (2000) 2.22
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol (1997) 2.19
Current therapy for cutaneous melanoma. J Am Acad Dermatol (1995) 2.19
Chemotherapy for colorectal carcinoma: one small step forward, one step backward. J Clin Oncol (1995) 2.16
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol (2002) 2.15
Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med (1987) 2.15
Work, income, the economy, and married fathers as child-care providers. Demography (1998) 2.15
The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer (1994) 2.14
Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J Clin Oncol (1998) 2.05
Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat Neurosci (2001) 2.04
Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood (1996) 2.01
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach. J Clin Oncol (1992) 1.98
Genetic organization of the region encoding regulation, biosynthesis, and transport of rhizobactin 1021, a siderophore produced by Sinorhizobium meliloti. J Bacteriol (2001) 1.97
Health services needs of children in day care centers. Am J Public Health (1978) 1.95
Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci (1999) 1.94
A European consensus on outcome measures for psychosocial intervention research in dementia care. Aging Ment Health (2008) 1.94
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer (2004) 1.94
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol (2009) 1.93
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer (2001) 1.92
Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology (1997) 1.91
Genes involved in sister chromatid separation and segregation in the budding yeast Saccharomyces cerevisiae. Genetics (2001) 1.89
Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg (1988) 1.87
A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol (1990) 1.86
Proposed standards for professional health sciences library services in hospitals of New York State. Bull Med Libr Assoc (1981) 1.85
Further investigations on the mode of entry of vaccinia virus into cells. J Gen Virol (1976) 1.85
Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol (1993) 1.84
Secondary structure predictions and medium range interactions. Biochim Biophys Acta (1987) 1.84
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol (1998) 1.80
Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer (1992) 1.78
Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Pain (2009) 1.77
Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York. Cancer Epidemiol Biomarkers Prev (1998) 1.77
Influence of body composition and resting metabolic rate on variation in total energy expenditure: a meta-analysis. Am J Clin Nutr (1995) 1.76
A search for life on Earth from the Galileo spacecraft. Nature (1993) 1.74
Updated gestational age specific birth weight, crown-heel length, and head circumference of Chinese newborns. Arch Dis Child Fetal Neonatal Ed (2003) 1.72
Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 1.72
Oncocytes, oncocytosis, and oncocytic tumors. Pathol Annu (1992) 1.69
Multiple milia during treatment with acitretin for mycosis fungoides. Acta Derm Venereol (1993) 1.68
Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 1.67
A cell-surface polysaccharide that facilitates rapid population migration by differentiated swarm cells of Proteus mirabilis. Mol Microbiol (1995) 1.67